Feb 18, 2021 — 3 min read
When we released a special version of our chest x-ray AI solution for COVID-19 in March of 2020, we were hoping that the pandemic would be gone by the end of the year. With COVID-19 variants and slow vaccine rollouts, however, it seems clear that COVID-19 is hardly fleeting anytime soon.
A year into the pandemic, lots of medical professionals have been using Lunit AI on a daily basis, to safely and accurately triage and manage COVID-19 patients. There have also been studies published in major peer-reviewed journals that validate the effectiveness of AI in COVID-19 settings. Take a look at the video below to learn about the key takeaways from the studies as well as how AI works in COVID-19 settings.
What do studies say about AI for COVID-19?
Performance of Lunit AI in COVID-19 pneumonia detection
The performance of Lunit AI in detecting COVID-19 pneumonia compared to that of thoracic radiologists
According to the study published in PLOS ONE, the overall performance of Lunit AI in detecting COVID-19 pneumonia on chest radiography was as high as that of thoracic radiologists. In particular, Lunit AI outperformed thoracic radiologist in sensitivity.
The study demonstrates that AI-aided chest radiography can be a reliable screening exam to identify COVID-19 patients, facilitating patient screening and isolation decisions and ultimately reducing the workload of medical staff during the pandemic.
Turnaround times of AI-aided chest radiography reports
The turnaround times of AI-aided CXR reports compared to those of rRT-PCR results
According to the study published in the Korean Journal of Radiology, the turnaround times of AI-aided chest radiography reports were significantly shorter than those of RT-PCR results, with 51 and 507 minutes, respectively.
The study suggests that AI-aided chest radiography interpretation can support timely decision-making and treatment, minimizing the spread of COVID-19 while waiting for RT-PCR results.
Visit our website dedicated to COVID-19. Upload a chest x-ray image in DICOM standard to see how accurately and quickly AI can detect COVID-19 infected pneumonia.
Though 2021 is going to be full of its travails, we have every hope that it will be immeasurably better for you, for your family and friends, and all of us. We wish you good health and a happy New Year.
Using AI to better manage COVID-19
Cognitive biases and augmented intelligence in radiology
Uncertainty and Deep Learning
What do the medical journals say about AI-powered mammography?
Research Using Lunit Demo Website
Lunit Presents AI-powered Pathologic Classification of Immune Phenotype that Predicts Response to Immunotherapy at USCAP 2021
What do the medical journals say about AI-powered chest x-ray interpretation?
Join our webinar with Dr. Fredrik Strand
From retrospective to prospective trials of AI in breast cancer screening
AACR 2021 - Lunit Presents Abstracts Demonstrating the Potential of its AI Biomarker in Cancer Treatment
Will AI Identify Breast Cancer Better Than Radiologists in Actual Clinical Screening?
Case of the Month | Where Is Breast Cancer?
AI-based Analysis of Cancer Tissue Predicts Response to Immunotherapy--Findings to Be Presented at ASCO 2021
Clinical Application of Lunit AI For Chest Radiography and Mammography to Be Presented at AOCR 2021
Lunit Secures $26M Investment from Guardant Health in a Strategic Funding Round
A Multi-reader Study Finds Unnecessary CT Exams Can Be Reduced by 30% When Analyzing Chest Radiographs with AI
Fujifilm Introduces its AI-powered Product for Chest X-ray in Japan, in Collaboration with Lunit
Lunit Collaborates with Intel to Provide AI Solutions to CPU-Based Customers in Need of Effective X-ray Diagnosis
Lunit AI Applied to Clinical Trial for Drug Development for the First Time--Findings Presented at ESMO 2021
Case of the Month (Chest x-ray)
COVID Global User Testimonials
Where is Cancer?
Breast Cancer Awareness Month — Ambassador Messages
TimeSformer: Is Space-Time Attention All You Need for Video Understanding?